OVERLAND PARK, KS--(Marketwired - Oct 28, 2014) - Durrie Vision, a Kansas City-based eye surgery center, served as one of five sites in a comprehensive study conducted by the Federal Drug Administration. The study was part of the LASIK Quality of Life Collaboration Project (LQOLCP) directed by the FDA, the National Eye Institute, and the Department of Defense.

Led by Dr. Daniel Durrie and Dr. Jason Stahl, Durrie Vision has a long history of leading and supporting research within the industry and was especially privileged to be a part of a study exclusively focused on patient safety, outcomes and satisfaction. Dr. Stahl notes, "For over 20 years, Durrie Vision has been committed to putting research into practice to improve patient outcomes. This particular study confirms previous findings that laser vision correction is both a safe and effective treatment for nearsightedness, farsightedness, and astigmatism."

Preliminary results from the study were released during the 2014 American Academy of Ophthalmology annual meeting and revealed overwhelmingly positive outcomes. Tracking and analyzing patient-reported symptoms from preoperative testing through 3-month postoperative visits, key findings from the study include:

  • Over 95% of the survey respondents achieved 20/20 or better visual acuity
  • The prevalence of symptoms such as glare, starburst, halos, and ghosting did not increase postoperatively after LASIK
  • More than 96% of subjects reported being satisfied with their vision after three months

Dr. Durrie served as an investigator in the study and was pleased with the FDA report. "The key positives in the study were that it showed the procedure was extremely safe and that ghosting, glare, halos and starburst went down after surgery. Overall, patients experienced improved symptoms after surgery and an extremely high satisfaction rate."

About Durrie Vision
Durrie Vision, in Overland Park, Kansas, is a world-class refractive surgery center and research department located in the heart of America. At Durrie Vision, our focus is on providing exceptional outcomes within a world-class patient experience. Our laser vision correction options, such as advanced LASIK and refractive lens procedures, have helped thousands of people enjoy better vision. We are committed to excellence because the world turns to us for answers, and our patients turn to us for the best quality of care and technology available. Our refractive surgeons -- Dr. Daniel S. Durrie and Dr. Jason E. Stahl -- are among the most experienced refractive surgeons in the country with international reputations as innovators and leaders in the field.

For more information about Durrie Vision, please visit durrievision.com or facebook.com/durrievision.

To view the original source of this press release, click here: http://www.durrievision.com/durrie-vision-news/durrie-vision-involved-in-fda-lasik-study/

Contact Information:

Durrie Vision
Courtney Moilanen
Director of Marketing
913.234.4119, ext. 7296

Rosemont Media